Polycystic ovary syndrome.
Dunaif
A
A
Section of Diabetes and Metabolism, Pennsylvania State University College of Medicine, Hershey.
D002996:Clomiphene / Q000009:adverse effects / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D008596:Menotropins / Q000009:adverse effects / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000517:prevention & control; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use
D003276:Contraceptives, Oral; D005938:Glucocorticoids; D002996:Clomiphene; D013148:Spironolactone; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins